Search - tctmd.com

Displaying 761 - 780 of 876

Sort: Relevancy | Date

Presentation TCT 2014

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

Presenter: Ran Kornowski

September 16, 2014

Presentation TCT 2014

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Presenter: Ian T. Meredith

September 15, 2014

Presentation TCT 2014

Con: The Future May Never Come!

Presenter: Simon Redwood, Neil E. Moat

September 15, 2014

Presentation TCT 2014

Pro: The Future Is Now!

Presenter: Simon Redwood, Alain G. Cribier

September 15, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Jose A. Condado, Jorge Villegas, Carlos Collet

September 15, 2014

Presentation TCT 2014

Case #3: A Patient with Aortic Stenosis, Occlusion of the Iliac and Subclavian Arteries, and a Porcelain Aorta

Presenter: Jose A. Condado, Jorge Villegas, Antonio Enrique Dager

September 15, 2014

Presentation TCT 2014

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Presenter: Graham A. Cassel, Hans R. Figulla, Greg L. Kaluza, Jochen Wöhrle, Peter Boekstegers

September 14, 2014

Presentation TCT 2014

Case #1: Complex Patient with NSTEMI and Severe Aortic Stenosis

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian, Pavel Cervinka

September 14, 2014

Presentation TCT 2014

Case Presentation #2: Aortic Stenosis in an Intermediate-Risk Patient

Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Adolfo G López Campanher

September 13, 2014

Presentation TCT 2014

Outcomes of TAVR and SAVR: Argentinean Registries

Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Miguel Oscar Payaslian

September 13, 2014

Presentation TCT 2014

TAVR Is Preferred for All but the Lowest-Risk Patients!

Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Alec S. Vahanian

September 13, 2014

Presentation TCT 2014

Surgery for All but the Highest-Risk Patients!

Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Jose Navia

September 13, 2014

Presentation TCT 2014

TCT 689: Three- and Five-Year Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Aortic Valve Implantation) Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Alison Duncan

September 13, 2014

Presentation TCT 2014

Thoughtful Perspectives on the Futile Patient with Aortic Stenosis

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Robert A. Guyton

September 13, 2014

Presentation TCT 2014

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow

September 13, 2014

Presentation TCT 2014

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Robert J. Applegate, Ronald Caputo, Steven J. Yakubov

September 13, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

Presentation TCT 2014

Hemodynamics of Aortic Stenosis and Live Calculations Using the Telestrator

Presenter: Thomas H. Maloney, John R. Zimmerman, Tim J. Lapp

September 13, 2014

Advertisement

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Con: The Future May Never Come!

Pro: The Future Is Now!

How Would I Treat This Patient?

Case #3: A Patient with Aortic Stenosis, Occlusion of the Iliac and Subclavian Arteries, and a Porcelain Aorta

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Case #1: Complex Patient with NSTEMI and Severe Aortic Stenosis

Case Presentation #2: Aortic Stenosis in an Intermediate-Risk Patient

Outcomes of TAVR and SAVR: Argentinean Registries

TAVR Is Preferred for All but the Lowest-Risk Patients!

Surgery for All but the Highest-Risk Patients!

TCT 689: Three- and Five-Year Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Aortic Valve Implantation) Registry

Thoughtful Perspectives on the Futile Patient with Aortic Stenosis

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Hemodynamics of Aortic Stenosis and Live Calculations Using the Telestrator

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content